Stay updated on F/TAF in HIV-1 Children & Adolescents Clinical Trial
Sign up to get notified when there's something new on the F/TAF in HIV-1 Children & Adolescents Clinical Trial page.

Latest updates to the F/TAF in HIV-1 Children & Adolescents Clinical Trial page
- Check2 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference0.6%
- Check9 days agoChange DetectedThe page has been updated to reflect a new version (v2.16.5) and the removal of a previous update regarding the modernization of ClinicalTrials.gov data ingest. The estimated last update notice has also been deleted.SummaryDifference0.7%
- Check16 days agoChange DetectedThe web page has been updated to reflect the latest details of a study evaluating Emtricitabine/Tenofovir Alafenamide (F/TAF) in HIV-1 infected children and adolescents, including new publication references and a revised study timeline. Notably, the study's primary objective remains unchanged, but some cohorts were not conducted as planned.SummaryDifference29%
- Check24 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
Stay in the know with updates to F/TAF in HIV-1 Children & Adolescents Clinical Trial
Enter your email address, and we'll notify you when there's something new on the F/TAF in HIV-1 Children & Adolescents Clinical Trial page.